Since the birth of Louise Brown in 1978, in vitro fertilization (IVF) has become the standard treatment for many types of infertility, despite an initial absence of research examining possible adverse effects on the mother or child. Delayed child bearing and increased access to infertility treatment have resulted in a dramatic increase in demand for IVF. In several European countries, assisted reproductive technology pregnancies represent 2-3% of all births, 1 whereas 0.7% of all U.S. births are the result of assisted reproductive technology. 2 Until recently, research has focused primarily on the efficacy of various assisted reproductive technology methods and the rates of early pregnancy loss or multiple gestations. Now some researchers have begun to question the safety of assisted reproductive technology in terms of its effects on the patient's health, her pregnancy, and her infant.
Recent studies have specifically addressed perinatal outcomes following IVF compared with spontaneous conception after controlling for maternal age, parity, multiple gestations, and other factors. Most studies found increases in preterm birth, low birth weight (LBW), or small for gestational age (SGA), [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] although a few did not. [17] [18] [19] [20] [21] Most individual studies had insufficient statistical power to detect significant differences in perinatal mortality. 6, 9, 13, 16, 20 Because of different study designs, populations, and reported outcomes, it is difficult to determine whether IVF pregnancies are at higher risk of adverse outcomes. Reviews on this topic have been neither systematic nor quantitative and have come to different conclusions. [22] [23] [24] [25] [26] We conducted a meta-analysis to evaluate whether singleton pregnancies conceived with IVF are at higher risk of perinatal mortality, preterm delivery, LBW, or SGA when compared with naturally conceived singleton pregnancies. Given the influence of maternal age and parity on obstetric outcome, 27, 28 only studies that controlled for maternal age and parity in either the design or analysis were included.
SOURCES
We searched MEDLINE and BIOSIS using a search strategy combining the keywords and subject terms "in vitro fertilization," "female infertility therapy," and "reproductive techniques" with "mortality," "fetal death," "fetal growth restriction," "small for gestational age," "preterm delivery," "premature labor," "birth weight," "infant," "obstetric," "perinatal," and "neonatal" for articles published between 1978 (the date of the first IVF birth) and October 2002. Animal studies and case reports were excluded. Conference proceedings available online and Doctoral Dissertations On-Line were also searched as were abstracts from the 1999 to 2001 meetings of the American Society of Reproductive Medicine, Society for Maternal Fetal Medicine, European Society for Human Reproduction and Embryology, and International Federation of Gynecology and Obstetrics. Bibliographies were reviewed to identify other relevant studies. Studies published in languages other than English were considered if an English abstract was provided.
STUDY SELECTION
Inclusion criteria were applied in 2 stages. First, we identified studies for blinded review that included a comparison of IVF singleton pregnancies to spontaneous conceptions and reported rates of perinatal mortality, preterm birth, LBW, very low birth weight (VLBW), or SGA in both groups. When the type of infertility treatment was unclear or the study group received a variety of treatments in addition to IVF, the study was submitted for further review. Two authors (R.J., K.G.) independently reviewed manuscripts meeting the above criteria after removing authors' names, journal titles, and funding sources. Final inclusion criteria were then applied: 1) comparison of IVF to spontaneous conception; 2) more than 50% in the IVF group had received standard IVF; 3) more than 50% in the spontaneous conception group were fertile; 4) control for at least maternal age and parity; 5) singleton gestations reported and analyzed separately from multiple gestations; 6) outcomes explicitly defined and including 1 of the above; and 7) risk ratios with 95% confidence intervals (CIs) provided or sufficient data to enable calculation. Standard IVF was defined as ovulation induction, egg retrieval, IVF and intrauterine embryo transfer of a fresh embryo. A third author (M.C.), blinded to study author and journal, settled discrepancies regarding inclusion criteria and data abstraction.
We excluded studies that compared a series of IVF births with population rates unadjusted for age or parity, studies where more than 50% of subjects received variations of standard IVF such as gamete intrafallopian transfer, IVF with intracytoplasmic sperm injection or cryopreserved or donor embryos, and studies of spontaneous conception in infertile women. When multiple publications reported data for the same study subjects, the most recent publication was selected. Study authors were asked to provide further information when it was unclear whether a study met our inclusion criteria.
Two authors (K.G., R.J.) abstracted data about study design, population, data collection methods, and raw data onto standardized forms. Study designs were classified as 1) traditional cohort: IVF births (exposed) comprised a subpopulation of a larger birth cohort (unexposed), and outcomes were compared between the 2 groups in their entirety; 2) matched cohort: IVF births comprised a subpopulation of a larger birth cohort, but only a matched group of the unexposed cohort was used for comparison; and 3) external comparison cohort (double cohort): IVF births were compared with a group of spontaneous conceptions from a different population.
Primary outcomes were defined as follows: SGA ϭ birth weight less than tenth percentile; preterm delivery ϭ delivery less than 37 completed weeks of gestation; LBW and VLBW ϭ weight less than 2,500 g and less than 1,500 g respectively; and perinatal mortality ϭ stillbirths plus early neonatal deaths (7 days or less). The definition of stillbirth ranged from more than 20 weeks to more than 28 weeks depending on the definition used in the author's locale; we used the author's definition of stillbirth in our analyses. Meta-analysis of secondary obstetric and neonatal outcomes was performed when 3 or more studies provided data for a given outcome. These included early preterm birth (less than 32-33 weeks), type of labor, delivery method, malpresentation, gestational diabetes, pregnancy-induced hypertension, vaginal bleeding, placenta previa, and neonatal intensive care unit admission. Definitions of secondary outcomes were taken directly from the included reports and in some cases differed between studies. Malformation rates were abstracted but are not analyzed because of extreme variability between studies in the definition and ascertainment of malformations.
Studies were assigned a quality score for use in stratified analysis. The score of 0 to 10 was based on 5 study design characteristics awarded 0 to 2 points as follows: traditional cohort ϭ 2 points, matched cohort ϭ 1, external comparison cohort ϭ 0; enrollment begun on or after 1990 ϭ 2, before 1990 ϭ 0; adjustment for age and parity only ϭ 1, for additional factors ϭ 2; delivery of both groups at the same hospital(s) ϭ 2, delivery of both groups region-wide ϭ 1; delivery of IVF group at 1-3 hospitals and spontaneous group region-wide ϭ 0; and more than 500 subjects in the IVF group ϭ 2, more than 300 ϭ 1, less than 300 ϭ 0.
We used adjusted odds ratios (ORs) from reports that provided them. For reports that provided multiple ORs for a given outcome, we chose the one that adjusted for age, parity, and delivery date. For studies that provided primary data and matched subjects for at least age and parity, we calculated ORs and 95% CIs using the method of Woolf. 29 When a zero cell was encountered, a value of 0.5 was added to each cell in the table. When a published OR was inconsistent with the raw data provided by the study, the effect measure was recalculated using the available data. When data were insufficient to calculate an OR, we attempted to contact the original authors.
Summary ORs were calculated by taking a weighted average of individual study results using a general variance-based, random-effects model, weighing individual study results by the inverse of their variance. 30 The weight for each study was the inverse of the sum of 2 terms: the study variance and a term accounting for the between-study variability. 30 We chose the randomeffects model because it is considered more conservative than a fixed effects model. In sensitivity analysis, we compared results of random and fixed effects models. We did not use the quality score in the calculation of weights of the individual studies. An OR less than 1.0 indicates a better outcome in the IVF group, whereas an OR greater than 1.0 favors the spontaneous conception group.
Heterogeneity was tested by using the general variance-based method 30 in which a conservative value of P Ͻ .10 was used to classify study results as heterogeneous. We attempted to identify sources of heterogeneity and bias by performing stratified analyses. We compared ORs in subgroups with differing study designs, delivery sites, study dates, sample sizes, and quality. Differences in the stratified summary estimates were evaluated using a z score. 29 A sensitivity analysis was performed to evaluate the stability of the overall risk estimate. Sensitivity analyses were performed separately for each of the 5 primary outcomes. Potential publication bias was investigated visually using funnel plots and mathematically using Egger's regression asymmetry test 31 and Kendall rank correlation test. 32 The Egger test evaluated whether the intercept deviated significantly from zero in a regression of standardized effect estimates against their precision. The Kendall test examined the significance of the Kendall rank correlation between the standardized effect sizes and their variances. All calculations were performed using STATA (StataCorp, College Station, TX).
RESULTS
Our initial search produced 1,452 citations. Of these, 1,415 did not meet initial screening criteria. These included case reports or series; unadjusted population-based IVF registry reports; reports of pregnancy rates, specific IVF methods, selective fetal reduction, and multiple gestation; and studies that did not report perinatal outcomes or that involved groups other than IVF and spontaneous conception. The remaining 37 articles were submitted for blinded evaluation. Of these, 13 were excluded because they did not match or adjust for maternal age and parity, 21,33-44 4 had fewer than 50% IVF in the infertile group, 10, 11, 45 ,46 2 did not analyze singletons separately from twins, 47 ,48 1 used a composite neonatal morbidity outcome, 49 1 included the same subjects in a more recent study, 19 and 1 did not match the standard IVF group to the spontaneous conception group. 50 The remaining 15 studies are summarized in Tables 1 and 2 . The author of a study published in Norwegian 7 provided English translation. The 15 studies include 12,283 IVF singleton pregnancies and 1.9 million spontaneously conceived singletons. Individual sample sizes ranged from 54 20 to 3,305 3 in the IVF group. All studies were retrospective and used variations of a cohort design: 3 were traditional cohort studies, 3, 5, 7 8 were matched cohort studies, 4,6,9,14 -18 and 4 were cohorts with an external comparison group. 8, 12, 13, 20 None of the studies were blinded in that obstetricians caring for the patients could have known that patients had received IVF. The majority of studies were performed in Europe, with 1 performed in the United States. 20 Study subjects were identified using hospital delivery logs, IVF clinic records, IVF registries, and regional or national birth registries. Two studies specifically excluded infertile women or women treated for infertility from the spontaneous conception group. 4, 16 Many studies included small proportions with non-IVF treatments in the IVF group. 3, 4, 8, 9, 13, 14, 18 In addition to age, parity, and delivery date, about half of the studies controlled for other factors such as ethnicity, insurance, smoking, body
Jackson et al IVF Meta-Analysis mass index, or obstetric history. 5,6,14 -18,20 . Only 4 controlled for delivery site. 6,16 -18 In the others, both groups delivered at hospitals throughout the region [3] [4] [5] 7, 9, 14, 15 or the IVF group delivered throughout the region and the spontaneous group delivered at 1 to 3 local hospitals. 8, 12, 13, 20 Individual study data and meta-analytic summary ORs for each primary outcome are shown in Figures  1-5 . The number of eligible studies and subjects for each outcome ranged from 7 studies with 1,889 IVF pregnancies for the outcome of SGA ( Figure 5 ), to 14 studies with 12,114 IVF pregnancies for the outcome of preterm delivery ( Figure 2 ). The overall incidence of each outcome in the IVF group was perinatal mortality 19.6/ 1,000, preterm delivery 11.5%, LBW 9.5%, VLBW 2.5%, and SGA 14.6%. Meta Statistical heterogeneity (P Ͻ .10) was not detected for perinatal mortality, VLBW, or SGA but was found for preterm delivery and LBW. Sources of heterogeneity for these outcomes were investigated by stratifying for study design, sample size, years of study, delivery site, and study quality ( Figure 6 ). The majority of subgroups had ORs that were similar to the overall summary OR and remained statistically significant. Heterogeneity that was present in the overall meta-analysis of preterm delivery and LBW was partially explained with stratification by study design features. For example, for both preterm delivery and LBW, smaller studies, those performed after 1990, with region-wide delivery of IVF births but local delivery of spontaneous conceptions, or with external comparison groups were not statistically heterogeneous (P Ͼ .10). Furthermore, higher-quality studies showed significantly higher odds of preterm birth and LBW than did lower-quality studies.
Sensitivity analyses were performed for each of the 5 primary outcomes. Sequential removal of each study from the meta-analyses resulted in no significant changes in the overall summary ORs. Fixed effects models produced similar results as random-effects models. A number of studies that were originally excluded were added in the sensitivity analyses. 10, 11, 21, 41, 46, 50 Addition of these did not change any of the summary ORs. Namely, when we included Schieve, 10 the largest study excluded, the OR for LBW changed from 1.77 to 1.76 and for VLBW from 2.70 to 2.51. For SGA, we added studies with slightly different definitions of SGA 10, 12, 13 with no change in the summary OR. Two studies that met our inclusion criteria were excluded in sensitivity analysis. Von During 7 reported adjusted relative risks instead of ORs. Tanbo 13 controlled for parity by including only nulliparous women in the spontaneous group. Exclusion of these studies did not change summary ORs for the associated outcomes. Details of these analyses are available on request. No evidence of publication bias was observed using funnel plots, Egger's regression asymmetry test, 31 or the Kendall rank correlation test 32 (data available on request).
Meta-analyses of secondary outcomes revealed that the IVF group had significantly higher ORs for stillbirth, early preterm delivery, spontaneous preterm birth, gestational diabetes, preeclampsia, placenta previa, vaginal bleeding, labor induction, elective and emergent cesarean, neonatal death, and neonatal intensive care unit admissions ( Figure 7 ). Data were insufficient to examine premature rupture of membranes, antepartum hospitalization, fetal distress, or Apgar scores.
DISCUSSION
Our meta-analysis suggests that singleton IVF pregnancies are associated with numerous adverse perinatal outcomes, including perinatal mortality, preterm delivery, LBW, and SGA, even after controlling for maternal age and parity. The findings were remarkably consistent: significantly increased ORs ranging from 1.6 to 2.7 were observed for all of the major perinatal outcomes and nearly all of the secondary outcomes. This consistency was observed despite varying study designs, patient populations, and IVF and obstetric protocols. Many have ascribed the higher rates of adverse outcomes to the effects of multiple gestations and the increased age and nulliparity of women who obtain IVF. 3, [51] [52] [53] [54] Our results refute this assertion in that we observed increased adverse outcomes even in studies of singleton gestations that controlled for 2 major confounders: maternal age and parity.
Absolute risks and risk differences are generally more useful in counseling patients than relative risks. However, summary absolute risk differences could not be estimated using these studies given that several studies either did not provide raw incidence data in the spontaneous group 3,14 or provided incidence rates unadjusted for age and parity. 5, 7 The absolute risks in the IVF group as a whole were clearly elevated as evidenced by the increased incidence of each outcome, ranging from 2.0% for perinatal mortality to 14.6% for SGA. These numbers can be used to approximate the absolute risk in IVF singletons as a group but are simple arithmetic averages and cannot be applied to individual patients. Furthermore, individualized risks based on age and parity would be clinically useful but were also not estimable from the data given.
A limitation of any meta-analysis, especially one based upon observational studies, is that biases in individual studies will be reflected in the summary statistics. The most likely source of bias in our meta-analysis is related to altered management of IVF pregnancies. Because IVF pregnancies are highly valued by patients and their doctors, these patients may be more likely to be hospitalized or to undergo labor induction or cesarean for minor complications, thus leading to iatrogenic increases in preterm delivery and LBW. Indeed, most studies reported higher rates of induced labor 6, 13, 16 and elective cesarean 6, 9, 13, 16, 18 in the IVF group. Could the adverse outcomes we observed be due to treatment bias? Out- 
558
Jackson et al IVF Meta-Analysis OBSTETRICS & GYNECOLOGY comes that are influenced by the obstetrician are certainly subject to treatment bias. However, treatment bias cannot account for outcomes that are less directly influenced by obstetric management such as perinatal mortality, early preterm birth, VLBW, SGA or placenta previa. For each of these "hard" outcomes, our metaanalysis showed significantly increased odds in the IVF group. Furthermore, some researchers eliminated the effect of labor induction and elective cesarean by examining preterm deliveries that occurred after spontaneous labor. 6, 12, 16, 18 The summary OR was increased in the IVF pregnancies. Finally, a few studies attempted to control for treatment bias by including only IVF and spontaneous deliveries occurring at the same site and managed using similar obstetric protocols. 6,16 -18 Again, the summary ORs were increased in the IVF group. If our results were due to treatment bias alone, one would expect lower ORs in the studies that controlled for delivery site and spontaneous labor.
Examination of the potential sources of heterogeneity among studies is one of the goals of meta-analysis. In our study, for outcomes that were relatively independent of treatment decisions such as SGA, very early preterm birth, VLBW and placenta previa, no heterogeneity was noted. However, for outcomes dependent on subjective management decisions like preterm delivery, cesarean, and LBW, significant heterogeneity was detected. This heterogeneity reflects the differing styles of management at each study center. Stratification by design features eliminated some of the heterogeneity in that recent, smaller, higher quality studies were more likely to lack heterogeneity. In fact, studies with higher quality scores not only showed less heterogeneity, they also showed significantly higher rates of preterm birth, perinatal mortality, and LBW than lower quality studies, further supporting the robustness of our results.
Results relating to the secondary outcomes should be interpreted with caution. We did not specifically search for studies with these outcomes. Our search was limited to studies reporting on preterm delivery, LBW, VLBW, SGA or perinatal mortality. Second, for some of the outcomes, definitions varied from study to study. For example, definitions of vaginal bleeding ranged from any self-reported bleeding to bleeding severe enough to warrant hospital admission. The causes of the increased risks we observed are unknown but could be due to the IVF procedure itself, to components of the IVF procedure, or to infertility per se. Recent studies by McElrath 45 and Draper 41 observed increased odds for VLBW and perinatal mortality in women with untreated infertility. To definitively address whether adverse outcomes are associated with infertility treatment as opposed to infertility would be ethically impossible, because it would require a randomized clinical trial comparing assisted conception with natural conception in fertile women. Clues can be obtained about the risks of assisted reproductive technology by comparing different subgroups of treated women. Wang 14 compared "low technology" treatments (intrauterine insemination, donor insemination), assisted reproductive technology, and spontaneous conceptions and found 50% increased odds for preterm birth in the low technology group and a 2-fold increase in the assisted reproductive technology group, indicating that both infertility itself and high technology treatments may be associated with increased preterm birth. Bergh 3 compared intracytoplasmic sperm injection , primarily performed for male factor infertility, with standard IVF, controlling for age and parity and found no statistically significant difference in preterm delivery or LBW, implying that fertile and infertile women undergoing IVF have similar outcomes. However, sample sizes were not given, so we were unable to determine whether there was adequate power. Several smaller studies have also compared intracytoplasmic sperm injection with IVF and generally found no difference in perinatal outcomes, [55] [56] [57] [58] [59] but it is unclear how many women in the intracytoplasmic sperm injection group were known to be fertile, and most studies did not report singleton gestations separate from multiples or control for maternal age and parity. Comparing stimulated with unstimulated cycles would isolate the effect of ovulation induction agents. Bergh 3 found no difference in outcomes for standard IVF compared with unstimulated IVF con- 
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Jackson et al IVF Meta-Analysis OBSTETRICS & GYNECOLOGY trolled for age and parity. Wennerholm 50 found a lower preterm delivery rate in unstimulated IVF with cryopreserved embryos compared with standard IVF. Oliveness 36 found no difference in preterm birth in those receiving only ovulation induction compared with IVF.
Future research should be conducted to further delineate the causes of the adverse outcomes observed in IVF singletons and attempt to better control for treatment biases. Given our findings, we recommend that informed consent for women undergoing IVF should include a discussion of possible perinatal risks. Furthermore, although obstetricians caring for these patients should consider IVF a risk factor for adverse perinatal outcomes, they should also be aware of the increased rates of labor induction and elective cesarean and attempt to avoid iatrogenic harm caused by preterm labor induction and cesarean.
